- Home
- TENX vs KZR Comparison
TENX vs KZR Comparison
Compare TENX & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- KZR
- Stock Information
- Founded
- TENX 1967
- KZR 2015
- Country
- TENX United States
- KZR United States
- Employees
- TENX N/A
- KZR N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- KZR Health Care
- Exchange
- TENX Nasdaq
- KZR Nasdaq
- Market Cap
- TENX 25.8M
- KZR 29.7M
- IPO Year
- TENX N/A
- KZR 2018
- Fundamental
- Price
- TENX $5.91
- KZR $4.07
- Analyst Decision
- TENX Strong Buy
- KZR Hold
- Analyst Count
- TENX 3
- KZR 2
- Target Price
- TENX $16.00
- KZR $9.00
- AVG Volume (30 Days)
- TENX 23.2K
- KZR 81.6K
- Earning Date
- TENX 08-19-2025
- KZR 08-19-2025
- Dividend Yield
- TENX N/A
- KZR N/A
- EPS Growth
- TENX N/A
- KZR N/A
- EPS
- TENX N/A
- KZR N/A
- Revenue
- TENX N/A
- KZR N/A
- Revenue This Year
- TENX N/A
- KZR N/A
- Revenue Next Year
- TENX N/A
- KZR N/A
- P/E Ratio
- TENX N/A
- KZR N/A
- Revenue Growth
- TENX N/A
- KZR N/A
- 52 Week Low
- TENX $3.25
- KZR $3.62
- 52 Week High
- TENX $7.89
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- TENX 43.41
- KZR 38.90
- Support Level
- TENX $5.80
- KZR $3.98
- Resistance Level
- TENX $6.25
- KZR $4.23
- Average True Range (ATR)
- TENX 0.26
- KZR 0.19
- MACD
- TENX -0.02
- KZR -0.04
- Stochastic Oscillator
- TENX 26.90
- KZR 9.56
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.